Relmada Therapeutics RLMD
NASDAQ RLMD
$4.27 +0.13 (+3.14%)
At close: Nov 10, 2026 · 4:00 PM EST

Relmada Therapeutics (RLMD) Debt Ratio (2014 - 2019)

Updated

Relmada Therapeutics' (RLMD) Debt Ratio came in at 0.00 for FY2019.

Analysis

Relmada Therapeutics (RLMD) Debt Ratio (2014 - 2019) Analysis & Trends

Since FY2014, Relmada Therapeutics has reported Debt Ratio for 6 years.

  • The FY2019 figure stands as the lowest annual Debt Ratio in data going back to FY2014.
  • Business Quant data shows RLMD's Debt Ratio at 1.06 in FY2018 (+985.4%), 0.10 in FY2017 (+265.1%), 0.03 in FY2016 (+147.1%) and 0.01 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 0.33
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.23
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 0.55
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 0.41
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 0.08
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 0.28
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 0.56
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 0.51
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 0.31
10 Relmada Therapeutics 473.10 Mn -85.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 0.00
Sep 30, 2019 0.03
Jun 30, 2019 0.04
Mar 31, 2019 0.01
Dec 31, 2018 0.03
Sep 30, 2018 2.31
Jun 30, 2018 1.06
Mar 31, 2018 0.34
Dec 31, 2017 0.23
Sep 30, 2017 0.19
Jun 30, 2017 0.10
Mar 31, 2017 0.01
Dec 31, 2016 0.02
Sep 30, 2016 0.02
Jun 30, 2016 0.03
Dec 31, 2015 0.01
Sep 30, 2015 0.01
Jun 30, 2015 0.01
Dec 31, 2014 0.00
Sep 30, 2014 0.01
API Access

Relmada Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=RLMD&period=max&api_key=YOUR_API_KEY